В ostium secundum atrial septal defect (asd) is a common congenital heart defect.
Ostium secundum atrial septal defect (asd) is a common congenital heart defect. The adverse prognosis of untreated asd diagnosed in childhood is well studied and percutaneous device closure of.
Ous device closure of asd in adults upon diagnosis, rather than waiting for symptoms or cardiac chamber dilatation. Keywords ostium secundum atrial septal defect (asd), congenital heart defect.
В atrial septal defects (asds) of secundum type are one of the most common congenital heart lesions in adults. Spontaneous closure is unusual in adults, and most of them develop symptoms like fatigue, dyspnea, or paradoxical embolization in the course of time.
Atrial septal defect (asd) is a common congenital heart defect, with an estimated birth prevalence of 1. Live births and a 97 probability of survival into adulthood 1, 2. Asdii constitutes about 75 of these defects, has a female predominance of approximately 21, and is frequently diagnosed in adulthood 3, 4.
Percutaneous management of coronary sinus atrial septal defect two cases representing the spectrum for device closure and a review of the literature.
Post mc, suttorp mj, jaarsma w, plokker hw comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defect in adults a single-center experience.
Background percutaneous closure of atrial septal defects is well established in children and adults and has been found to improve symptoms and positively influence right-heart remodeling. The aim of this study was to evaluate the efficacy and long-term outcome in adult patients older than 60 years. Methods and results the study population comprised 96 patients in the age group of 60 to.
Atrial tachyarrhythmias following percutaneous device closure of secundum atrial septal defects. Linin-hospital and 4-year clinical outcomes following transcatheter versus surgical closure for secundum atrial septal defect in adults a. Hijazitranscatheter device closure of atrial septal defects in patients older than.